MRI of Prostate Cancer

  • Nikolaos V. Kritikos


MR imaging of the prostate emerged as a new diagnostic tool for the study of prostate cancer in the mid-1980s. Ever since new MR techniques have evolved making MR prostate imaging a promising modality for detecting and staging of the prostate tumors. Basic morphologic sequences (T1 weighted and T2 weighted) in combination with recent advances which include functional and physiologic MR imaging techniques allow a more sophisticated approach of the prostate cancer, adding new information beyond the traditional morphologic assessment. In addition, the quality of the performed MRI exams of the prostate is essentially improved using new imaging unit hardware and software. Another era of advance is the development of MR-compatible devices, allowing invasive procedures as targeted prostate biopsy to be performed.


  1. 1.
    Oto A, Kayhan A, Jiang Y et al (2010) Prostate cancer: differentiation of central gland cancer form benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology 217:715–723CrossRefGoogle Scholar
  2. 2.
    Sadha V, Baris T, Naira M et al (2012) Overview of dynamic contrast – enhanced MRI in prostate cancer diagnosis and management. AJR 198:1277–1288CrossRefGoogle Scholar
  3. 3.
    Woodfield C, Tung G, Grand D et al (2010) Diffusion weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy. AJR 194:316–322CrossRefGoogle Scholar
  4. 4.
    Jung JA, Coakley FV, Vigneron PB et al (2004) Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. Radiology 233:701–708CrossRefGoogle Scholar
  5. 5.
    Young Jun C, Jeong Kon K, Namkug K et al (2007) Functional MR imaging of prostate cancer. Radiology 27:63–75Google Scholar
  6. 6.
    Weinreb JC, Barentsz JO, Choyke PL et al (2016) PI-RADS prostate imaging - reporting and data system: 2015, version 2. Eur Urol 69:16–40CrossRefGoogle Scholar
  7. 7.
    Heesakkers RA, Hövels AM, Jager GJ et al (2008) MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multi-cohort study. Lancet Oncol 9(9):850–856CrossRefGoogle Scholar
  8. 8.
    Jo YH, Sad V, Jo MS et al (2012) Imaging guided prostate biopsy: conventional and emerging techniques. Radiographics 32:819–837CrossRefGoogle Scholar
  9. 9.
    Visscherc De P, Meerleer De G, Fütterer J, Villeirs G (2010) Role of MRI in follow-up after local therapy for prostate carcinoma. AJR 194:1427–1433CrossRefGoogle Scholar
  10. 10.
    Ho B, Richenberq J, Clements R et al (2012) ESUR prostate MR guidelines 2012. Eur Radiol 22(4):746–747CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Nikolaos V. Kritikos
    • 1
  1. 1.Director of Imaging DepartmentMitera HospitalAtticaGreece

Personalised recommendations